Patents by Inventor Benjamin Margolis
Benjamin Margolis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 10952901Abstract: A system and process for treating retinal diseases includes passing a plurality of radiant beams, i.e., laser light beams, through an optical lens or mask to optically shape the beams. The shaped beams are applied to at least a portion of the retina. Due to the selected parameters of the beams—pulse length, power and duty cycle—the beams can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal phototherapy or photostimulation.Type: GrantFiled: January 7, 2019Date of Patent: March 23, 2021Assignee: Ojai Retinal Technology, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Publication number: 20190159932Abstract: A system and process for treating retinal diseases includes passing a plurality of radiant beams, i.e., laser light beams, through an optical lens or mask to optically shape the beams. The shaped beams are applied to at least a portion of the retina. Due to the selected parameters of the beams—pulse length, power and duty cycle—the beams can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal phototherapy or photostimulation.Type: ApplicationFiled: January 7, 2019Publication date: May 30, 2019Applicant: Ojai Retinal Technology, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Patent number: 10219947Abstract: A system and process for treating retinal diseases includes passing a plurality of radiant beams, i.e., laser light beams, through an optical lens or mask to optically shape the beams. The shaped beams are applied to at least a portion of the retina. Due to the selected parameters of the beams—pulse length, power and duty cycle—the beams can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal phototherapy or photostimulation.Type: GrantFiled: March 13, 2013Date of Patent: March 5, 2019Assignee: Ojai Retinal Technology, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Publication number: 20170259049Abstract: Embodiments herein are directed to a hemostatic medical device including an applicator having a receptacle with an output end and a moveable piston configured to move at least partially within the receptacle, and a plurality of liquid expandable articles disposed within the applicator, wherein each liquid expandable article has a volume greater than 50 mm3.Type: ApplicationFiled: May 19, 2017Publication date: September 14, 2017Applicant: Oregon Biomedical Engineering InstituteInventors: Kenton W. Gregory, Lauryn L. Baranowski, Arjun Kalyanpur, Seanna Vine, Grant Blackwell, Benjamin Margolis, Steven Dell
-
Patent number: 9656050Abstract: Embodiments herein comprise a hemostatic composition comprising a plurality of liquid expandable articles capable of expanding upon contact with a liquid. A suitable composition comprises a plurality of liquid-expandable articles that may be mechanically uncoupled from one another and therefore may be capable of moving independently from one another. The plurality of liquid-expandable articles may comprise a compressed material capable of a high-degree of expansion upon liquid contact.Type: GrantFiled: September 2, 2014Date of Patent: May 23, 2017Assignee: Oregon Biomedical Engineering InstituteInventors: Kenton W. Gregory, Lauryn L. Baranowski, Arjun Kalyanpur, Seanna Vine, Grant Blackwell, Benjamin Margolis, Steven Dell
-
Patent number: 9381115Abstract: A system and process for treating retinal diseases includes passing a laser light beam through an optical lens or mask to optically shape the light beam. The light beam is applied to at least a portion of the retina. Due to the selected parameters of the laser light beam pulse length, power and duty cycle, the laser light beam can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal photocoagulation.Type: GrantFiled: May 25, 2012Date of Patent: July 5, 2016Assignee: Ojai Retinal Technology, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Patent number: 9168174Abstract: A process for restoring responsiveness to medication in eye tissue, namely retinal tissue, that is unresponsive to medication. The process utilizes a laser source for generating a confluent, contiguous laser light beam. The laser light beam is preferably a subthreshold diode micropulse laser beam which is optically shaped through an optical lens or mask. The tissue is then exposed to the confluent, contiguous laser light beam and allowed to recover for thirty days before administering medication to which the tissue was unresponsive.Type: GrantFiled: January 28, 2015Date of Patent: October 27, 2015Assignee: Ojai Retinal Technology, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis, David B. Chang
-
Publication number: 20150157498Abstract: A process for restoring responsiveness to medication in eye tissue, namely retinal tissue, that is unresponsive to medication. The process utilizes a laser source for generating a confluent, contiguous laser light beam. The laser light beam is preferably a subthreshold diode micropulse laser beam which is optically shaped through an optical lens or mask. The tissue is then exposed to the confluent, contiguous laser light beam and allowed to recover for thirty days before administering medication to which the tissue was unresponsive.Type: ApplicationFiled: January 28, 2015Publication date: June 11, 2015Applicant: OJAI RETINAL TECHNOLOGY, LLCInventors: Jeffrey K. Luttrull, Benjamin Margolis, David B. Chang
-
Publication number: 20150057696Abstract: Embodiments herein comprise a hemostatic composition comprising a plurality of liquid expandable articles capable of expanding upon contact with a liquid. A suitable composition comprises a plurality of liquid-expandable articles that may be mechanically uncoupled from one another and therefore may be capable of moving independently from one another. The plurality of liquid-expandable articles may comprise a compressed material capable of a high-degree of expansion upon liquid contact.Type: ApplicationFiled: September 2, 2014Publication date: February 26, 2015Inventors: Kenton W. Gregory, Lauryn L. Baranowski, Arjun Kalyanpur, Seanna Vine, Grant Blackwell, Benjamin Margolis, Steven Dell
-
Publication number: 20140330352Abstract: A retina phototherapy system having a substantially horizontal working surface with an adjustable, ergonomic headrest assembly. A retina phototherapy device is adjustably disposed on the working surface and generally includes laser optics, a camera, a flat screen monitor, and a control joystick. The laser optics are oriented generally in the direction of the headrest assembly and are configurable so as to focus on a retina of a person using the headrest assembly. The camera is generally coaxially disposed with the laser optics and connected to the monitor so as to project an image of the retina treatment area. The control joystick is configured to micro-adjust a position of the retina phototherapy device in relation to the working surface.Type: ApplicationFiled: July 16, 2014Publication date: November 6, 2014Inventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Patent number: 8828050Abstract: Embodiments herein comprise a hemostatic composition comprising a plurality of liquid expandable articles capable of expanding upon contact with a liquid. A suitable composition comprises a plurality of liquid-expandable articles that may be mechanically uncoupled from one another and therefore may be capable of moving independently from one another. The plurality of liquid-expandable articles may comprise a compressed material capable of a high-degree of expansion upon liquid contact.Type: GrantFiled: May 4, 2010Date of Patent: September 9, 2014Assignee: Oregon Biomedical Engineering InstituteInventors: Kenton W. Gregory, Lauryn L. Baranowski, Arjun Kalyanpur, Seanna Vine, Grant Blackwell, Benjamin Margolis, Steven Dell
-
Publication number: 20130317487Abstract: A system and process for treating retinal diseases includes passing a plurality of radiant beams, i.e., laser light beams, through an optical lens or mask to optically shape the beams. The shaped beams are applied to at least a portion of the retina. Due to the selected parameters of the beams—pulse length, power and duty cycle—the beams can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal phototherapy or photostimulation.Type: ApplicationFiled: March 13, 2013Publication date: November 28, 2013Inventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Publication number: 20130317570Abstract: A system and process for treating retinal diseases includes passing a laser light beam through an optical lens or mask to optically shape the light beam. The light beam is applied to at least a portion of the retina. Due to the selected parameters of the laser light beam pulse length, power and duty cycle, the laser light beam can be applied to substantially the entire retina, including the fovea, without damaging retinal or foveal tissue, while still attaining the benefits of retinal photocoagulation.Type: ApplicationFiled: May 25, 2012Publication date: November 28, 2013Inventors: Jeffrey K. Luttrull, Benjamin Margolis
-
Publication number: 20110077682Abstract: The present invention is directed to a composition comprising a plurality of small, liquid-expandable articles and their use to induce hemostasis when applied to bleeding wounds.Type: ApplicationFiled: May 4, 2010Publication date: March 31, 2011Inventors: Kenton W. Gregory, Lauryn L. Baranowski, Arjun Kalyanpur, Seanna Vine, Grant Blackwell, Benjamin Margolis, Steven Dell
-
Publication number: 20050032689Abstract: The present invention concerns methods for diagnosis and treatment of diseases or disorders characterized by abnormal cellular signal transduction involving a newly identified region, herein termed the “APB domain.” APB domain binding between proteins is believed to play an important role in signal transduction pathways and, thereby, influence cellular events. Thus, APB mediated activity plays a role in signal transduction pathways and agents modulating APB mediated activity can be used to treat diseases or disorders involving proteins containing APB domains.Type: ApplicationFiled: November 10, 2003Publication date: February 10, 2005Inventors: Benjamin Margolis, Joseph Schlessinger, Vijay Yajnik
-
Publication number: 20050026228Abstract: The present invention relates to compositions and methods for the prevention, prognostic evaluation, and treatment of oncogenic disorders, especially breast cancer, wherein a protein tyrosine kinase capable of complexing with a member of the SH2-and/or SH3-containing family of adaptor proteins is involved. In a preferred embodiment of the invention, the protein tyrosine kinase is the receptor protein tyrosine kinase HER2, and the adaptor protein is GRB, so that the protein tyrosine kinase/adaptor protein complex is a HER2/GRB-7 complex.Type: ApplicationFiled: October 7, 2003Publication date: February 3, 2005Inventor: Benjamin Margolis